Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare
Salarius Pharmaceuticals, Inc. EPS 2015–2022
Salarius Pharmaceuticals, Inc. annual/quarterly eps history and growth rate from 2020 to 2023. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Salarius Pharmaceuticals, Inc. eps for the quarter ending March 31, 2023 was $2.23, a 32.42% decrease year-over-year.
- Salarius Pharmaceuticals, Inc. annual eps for 2022 was $14.88, a 92.75% increase from 2021.
- Salarius Pharmaceuticals, Inc. annual eps for 2021 was $7.72, a 1444.00% increase from 2020.
- Salarius Pharmaceuticals, Inc. annual eps for 2020 was $0.50.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Salarius Pharmaceuticals, Inc. EPS — FAQ
Salarius Pharmaceuticals, Inc. (DCOY) eps over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Salarius Pharmaceuticals, Inc.'s eps?
Salarius Pharmaceuticals, Inc. (DCOY) reported eps of $-14.88 for fiscal 2022.
Where can I see DCOY's eps history?
The chart and table above show Salarius Pharmaceuticals, Inc.'s eps by year and by quarter, including the growth rate.